{"id":60802,"date":"2024-02-28T07:09:25","date_gmt":"2024-02-28T07:09:25","guid":{"rendered":"https:\/\/medsname.com\/unicontin-e\/"},"modified":"2026-04-30T10:23:42","modified_gmt":"2026-04-30T10:23:42","slug":"unicontin-e","status":"publish","type":"product","link":"https:\/\/medsbase.com\/hu\/product\/unicontin-e\/","title":{"rendered":"Unicontin-E"},"content":{"rendered":"<div class=\"medsbase-tldr-answer\" style=\"background:#fff8e1;border-left:4px solid #f5a623;padding:18px 22px;margin:0 0 28px 0;border-radius:4px;\">\n<h3 style=\"margin:0 0 10px 0;font-size:18px;color:#1a1a1a;\">\u26a1 Quick Answer \u2014 What is Unicontin-E?<\/h3>\n<p><strong>Unicontin-E<\/strong> tartalmaz <strong>theophylline<\/strong>, amely <strong>metilxantin bronchodilat\u00e1tor<\/strong> gyullad\u00e1scs\u00f6kkent\u0151 hat\u00e1ssal, kr\u00f3nikus asztma \u00e9s COPD kieg\u00e9sz\u00edt\u0151 ter\u00e1pi\u00e1jak\u00e9nt haszn\u00e1lj\u00e1k. A teofilin t\u00f6bb c\u00e9lpontra hat \u2014 foszfodieszter\u00e1z g\u00e1tl\u00e1s (cAMP szint n\u00f6vel\u00e9se), adenozin receptor antagonizmus \u00e9s HDAC2 aktiv\u00e1l\u00e1s (gyullad\u00e1scs\u00f6kkent\u00e9s). <strong>kesz ter\u00e1pi\u00e1s index<\/strong> (target serum 10\u201320 mg\/L; toxicity at 20+) and many drug interactions, requiring careful dosing and (in some patients) blood-level monitoring. Each controlled-release tablet contains <strong>400 mg<\/strong>, 10 ml-es \u00fcvegben forgalmazott. A szuszpenzi\u00f3s forma lehet\u0151v\u00e9 teszi a pontos tests\u00falyalap\u00fa adagol\u00e1st m\u00e9g a tablett\u00e1t nem tud\u00f3 gyermekekn\u00e9l is, valamint hasznos feln\u0151ttekn\u00e9l is nyel\u00e9si neh\u00e9zs\u00e9gek eset\u00e9n. <strong>Modi-Mundipharma<\/strong> WHO-GMP tan\u00fas\u00edtott l\u00e9tes\u00edtm\u00e9nyekben.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background:#f4f8fb;border:1px solid #d8e3eb;padding:12px 16px;margin:16px 0;border-radius:4px;font-size:14px;\">\n<strong>Mit kapsz a MedsBase-n\u00e1l:<\/strong> WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3 \u00b7 Diszkr\u00e9t csomagol\u00e1s \u00b7 Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s \u00b7 1.400+ hiteles\u00edtett <a href=\"https:\/\/medsbase.com\/hu\/reviews\/\">v\u00e1s\u00e1rl\u00f3i v\u00e9lem\u00e9ny<\/a>\n<\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size:14px;color:#444;margin:8px 0 18px;\">\ud83d\udce6 Minden rendel\u00e9st fedez a <a href=\"https:\/\/medsbase.com\/hu\/medsbase-re-shipment-assurance-policy\/\"><strong>\u00dajrak\u00fcld\u00e9si Garancia<\/strong><\/a> \u2014 ha a csomagod nem \u00e9rkezik meg 20 munkanapon bel\u00fcl, \u00fajrak\u00fcldj\u00fck.<\/p>\n<h3>Mi\u00e9rt rendelj a MedsBase-r\u00f3l<\/h3>\n<p>Generikus gy\u00f3gyszereink WHO-GMP min\u0151s\u00edt\u00e9s\u0171 gy\u00e1rt\u00f3kt\u00f3l sz\u00e1rmaznak, \u00e9s diszkr\u00e9t, egyszer\u0171 csomagol\u00e1sban sz\u00e1ll\u00edtjuk \u0151ket vil\u00e1gszerte \u2014 a csomagon nem szerepel a gy\u00f3gyszer neve. A k\u00e1rty\u00e1s fizet\u00e9sek egy szab\u00e1lyozott feldolgoz\u00f3n kereszt\u00fcl t\u00f6rt\u00e9nnek (a sz\u00e1mlale\u00edr\u00e1sok egy szab\u00e1lyozott k\u00e1rtyafizet\u00e9si feldolgoz\u00f3t tartalmaznak \u2014 soha nem \u201cMedsBase\u201d vagy b\u00e1rmilyen gy\u00f3gyszer neve). Kriptovalut\u00e1t \u00e9s SEPA banki \u00e1tutal\u00e1st is elfogadunk. Minden rendel\u00e9st a Reshipment Assurance Policy biztos\u00edt\u00e9k fedez.<\/p>\n<div style=\"background:#f4f8fb;border:1px solid #e0e0e0;padding:12px 18px;margin:0 0 24px 0;border-radius:4px;font-size:14px;text-align:center;\">\n<strong>\ud83d\udd12 Titkos\u00edtott fizet\u00e9s<\/strong> \u00b7 <strong>\ud83d\udcb3 Hiteles\u00edtett feldolgoz\u00f3<\/strong> \u00b7 <strong>\ud83d\ude9a Vil\u00e1gszerte sz\u00e1ll\u00edt\u00e1s<\/strong> \u00b7 <strong>\u2b50 4,9\/5 1400+ v\u00e1s\u00e1rl\u00f3 \u00e9rt\u00e9kel\u00e9se alapj\u00e1n<\/strong>\n<\/div>\n<h2>What Is Unicontin-E?<\/h2>\n<p>Unicontin-E is an oral methylxanthine bronchodilator. Methylxanthines are derived from natural alkaloids (theophylline is the dimethylxanthine present in tea). Their use has declined since the 1990s as inhaled \u03b22-agonists and corticosteroids became first-line \u2014 but they retain a role as third-line add-on therapy in difficult asthma and COPD.<\/p>\n<h2>How Does Unicontin-E Work?<\/h2>\n<ul>\n<li><strong>A foszfodi\u00e9szter\u00e1z g\u00e1tl\u00e1sa (PDE3, PDE4)<\/strong> \u2014 n\u00f6veli a ciklikus AMP-t a l\u00e9g\u00fati simaizmokban \u00e9s a gyullad\u00e1sos sejtekben; a v\u00e9geredm\u00e9ny h\u00f6rg\u00e9sdilat\u00e1ci\u00f3 \u00e9s cs\u00f6kkentett medi\u00e1torfelszabad\u00edt\u00e1s.<\/li>\n<li><strong>Adenozin receptor antagonizmus<\/strong> \u2014 blokkolja az adenozin k\u00f6zvet\u00edtett bronchoconstrictort \u00e9s a mastsejt medi\u00e1torfelszabad\u00edt\u00e1st.<\/li>\n<li><strong>HDAC2 aktiv\u00e1l\u00e1s<\/strong> (teofillin alacsony sz\u00e9rum szinten 5\u201310 mg\/L) \u2013 helyre\u00e1ll\u00edtja a kortikoszteroid \u00e9rz\u00e9kenys\u00e9get COPD-ben \u00e9s s\u00falyos asztm\u00e1ban, ahol a szteroid rezisztencia r\u00e9szben cs\u00f6kkent HDAC2 \u00e1ltal medi\u00e1lt.<\/li>\n<li><strong>Rekeszizom \u00f6sszeh\u00faz\u00f3d\u00f3k\u00e9pess\u00e9g<\/strong> \u2013 a metilxantinok cs\u00f6kkentik a rekeszizom f\u00e1radts\u00e1got, hasznos COPD-ben s\u00falyos l\u00e9g\u00fati korl\u00e1toz\u00e1ssal.<\/li>\n<\/ul>\n<h2>Felhaszn\u00e1l\u00e1s \u00e9s indik\u00e1ci\u00f3k<\/h2>\n<ul>\n<li><strong>S\u00falyos kr\u00f3nikus asztma<\/strong> \u2013 kieg\u00e9sz\u00edt\u00e9s nagy d\u00f3zis\u00fa ICS-LABA mellett, ahol tov\u00e1bbi h\u00f6rg\u0151t\u00e1g\u00edt\u00e1sra van sz\u00fcks\u00e9g<\/li>\n<li><strong>COPD karbantart\u00f3 kezel\u00e9s<\/strong> \u2013 kieg\u00e9sz\u00edt\u00e9s LAMA-LABA vagy h\u00e1rmas ter\u00e1pia mellett<\/li>\n<li><strong>Nokturn\u00e1lis asztma<\/strong> \u2013 lass\u00fa felszabadul\u00e1s\u00fa k\u00e9sz\u00edtm\u00e9ny \u00e9jszakai h\u00f6rg\u0151t\u00e1g\u00edt\u00e1st biztos\u00edt<\/li>\n<li><strong>Korasz\u00fcl\u00f6tt apnoe<\/strong> (teofillin) \u2013 \u00fajsz\u00fcl\u00f6ttkori haszn\u00e1lat<\/li>\n<li><strong>Cor pulmonale \u00e9s t\u00fcd\u0151i hypertonia<\/strong> \u2014 kieg\u00e9sz\u00edt\u0151 ter\u00e1pia<\/li>\n<\/ul>\n<h2>Unicontin-E Dosage<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Betegek<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Dose<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Gyakoris\u00e1g<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Feln\u0151ttek \u2014 kezdeti<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>200 mg<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Twice daily; titrate to serum level 10\u201320 mg\/L<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Feln\u0151ttek \u2014 karbantart\u00f3<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\"><strong>400 mg<\/strong><\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Twice daily (or 600 mg once daily ER)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Elderly \/ heart failure \/ liver disease<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Felezze az adagot<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Monitor serum level<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Side Effects of Unicontin-E<\/h2>\n<ul>\n<li>H\u00e1nyinger, h\u00e1ny\u00e1s, gyomorf\u00e1j\u00e1s<\/li>\n<li>Fejf\u00e1j\u00e1s<\/li>\n<li>Tremor<\/li>\n<li>\u00c1lmatlans\u00e1g, nyugtalans\u00e1g<\/li>\n<li>Tachycardia, palpitatio<\/li>\n<li>Enyhe hipokal\u00e9mia magas adagokn\u00e1l<\/li>\n<\/ul>\n<p><strong>Toxikus szint (&gt;20 mg\/L) \u2013 v\u00e9szhelyzet:<\/strong><\/p>\n<ul>\n<li>S\u00falyos h\u00e1nyinger, kitart\u00f3 h\u00e1ny\u00e1s<\/li>\n<li>Sz\u00edvritmuszavar (pitvarfibrill\u00e1ci\u00f3, szupraventrikul\u00e1ris tachycardia)<\/li>\n<li>Roham (gyakran figyelmeztet\u00e9s n\u00e9lk\u00fcl)<\/li>\n<li>Hypot\u00f3nia, hiperglik\u00e9mia, hipok\u00e1li\u00e9mia, hiperkalc\u00e9mia<\/li>\n<\/ul>\n<h2>Figyelmeztet\u00e9sek \u00e9s el\u0151vigy\u00e1zatoss\u00e1g<\/h2>\n<ul>\n<li><strong>Keskeny ter\u00e1pi\u00e1s index.<\/strong> C\u00e9lszerum 10\u201320 mg\/L. Ellen\u0151rizze a v\u00e9rszintet kezd\u00e9s ut\u00e1n 5 nappal, adagv\u00e1ltoztat\u00e1s ut\u00e1n, \u00faj interakci\u00f3ba l\u00e9p\u0151 gy\u00f3gyszer eset\u00e9n, doh\u00e1nyz\u00e1s abbahagy\u00e1sakor \u00e9s betegs\u00e9g\/l\u00e1z alatt (a clearance cs\u00f6kken).<\/li>\n<li><strong>Sz\u00e1mos gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1s<\/strong> \u2014 l\u00e1sd az interakci\u00f3s t\u00e1bl\u00e1zatot. F\u0151leg CYP1A2 metaboliz\u00e1lja; sz\u00e1mos g\u00e1tl\u00f3 \u00e9s induk\u00e1l\u00f3 anyag jelent\u0151sen m\u00f3dos\u00edtja a szintet.<\/li>\n<li><strong>Doh\u00e1nyz\u00e1s<\/strong> induk\u00e1lja a CYP1A2-t \u00e9s ~50%-kal cs\u00f6kkenti a teofillin szintet \u2014 \u00fajra titr\u00e1l\u00e1s sz\u00fcks\u00e9ges a doh\u00e1nyz\u00e1s abbahagy\u00e1sakor.<\/li>\n<li><strong>Sz\u00edvbetegs\u00e9g:<\/strong> \u00f3vatosan alkalmazni sz\u00edvritmuszavarokn\u00e1l, sz\u00edvel\u00e9gtelens\u00e9gn\u00e9l, s\u00falyos hypertoni\u00e1n\u00e1l.<\/li>\n<li><strong>Hyperthyreosis:<\/strong> fokozott clearance \u00e9s er\u0151s\u00f6d\u00f6tt adrenerg hat\u00e1sok.<\/li>\n<li><strong>Terhess\u00e9g \u00e9s szoptat\u00e1s:<\/strong> \u00e1ltal\u00e1ban ker\u00fclend\u0151; csak nyilv\u00e1nval\u00f3 haszon eset\u00e9n alkalmazhat\u00f3.<\/li>\n<li><strong>M\u00e1jbetegs\u00e9g:<\/strong> cs\u00f6kkentse az adagot \u2014 a metilxantinok m\u00e1jban metaboliz\u00e1l\u00f3dnak.<\/li>\n<\/ul>\n<h2>Ellenjavallatok<\/h2>\n<ul>\n<li>Theophylline vagy m\u00e1s xantinokra (koffein, theobromin) \u00e9rz\u00e9kenys\u00e9g<\/li>\n<li>Akt\u00edv peptikus fek\u00e9lybetegs\u00e9g<\/li>\n<li>Nem kontroll\u00e1lt tachyarrhythmi\u00e1k<\/li>\n<li>S\u00falyos sz\u00edvel\u00e9gtelens\u00e9g (NYHA IV)<\/li>\n<\/ul>\n<h2>Gy\u00f3gyszerk\u00f6lcs\u00f6nhat\u00e1sok<\/h2>\n<table style=\"border-collapse:collapse;width:100%;margin:12px 0;\">\n<thead>\n<tr style=\"background:#2c7cb0;color:#fff;\">\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Interakci\u00f3ba l\u00e9p\u0151 gy\u00f3gyszer<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Hat\u00e1s<\/th>\n<th style=\"padding:10px;border:1px solid #ddd;text-align:left;\">Teend\u0151k<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ciprofloxacin, erythromycin, clarithromycin, fluvoxamine<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">G\u00e1tolj\u00e1k a CYP1A2-t \u2192 emelkedik a teofillin szint \u2192 toxicit\u00e1s (h\u00e1nyinger, sz\u00edvritmuszavar, g\u00f6rcs\u00f6k)<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Ker\u00fclje vagy cs\u00f6kkentse a teofillin adagot 50%-kal; ellen\u0151rizze a sz\u00e9rum szintet<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Cimetidin, allopurinol<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">N\u00f6veli a teofillin szintj\u00e9t<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Cs\u00f6kkentse az adagot; monitorozza a szinteket<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">Fenitoin, karbamazepin, rifampicin<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">CYP-induk\u00e1l\u00f3 \u2014 alacsonyabb szintek<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Nagyobb adagra lehet sz\u00fcks\u00e9g<\/td>\n<\/tr>\n<tr style=\"background:#f9f9f9;\">\n<td style=\"padding:10px;border:1px solid #ddd;\">Doh\u00e1nyz\u00e1s<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">CYP1A2-induk\u00e1l\u00f3 \u2014 alacsonyabb szintek<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">D\u00f3zis \u00fajratitr\u00e1ci\u00f3ja a doh\u00e1nyz\u00e1s abbahagy\u00e1sakor<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:10px;border:1px solid #ddd;\">\u03b2-agonist\u00e1k, diuretikumok<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Addit\u00edv hypokalaemia<\/td>\n<td style=\"padding:10px;border:1px solid #ddd;\">Figyelje a k\u00e1lium szintj\u00e9t<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>T\u00e1rol\u00e1s<\/h2>\n<ul>\n<li>T\u00e1rol\u00e1s 25\u00b0C alatt <strong>25\u00b0C<\/strong> h\u0171v\u00f6s, sz\u00e1raz helyen, k\u00f6zvetlen napf\u00e9nyt\u0151l t\u00e1vol.<\/li>\n<li>Az eredeti csomagol\u00e1sban tartva haszn\u00e1latig, hogy v\u00e9dve legyen a nedvess\u00e9gt\u0151l \u00e9s a f\u00e9nyt\u0151l.<\/li>\n<li>Ne haszn\u00e1lja a csomagol\u00e1son felt\u00fcntetett lej\u00e1rati d\u00e1tum lej\u00e1rta ut\u00e1n.<\/li>\n<li>Tartsa gyermekekt\u0151l el\u00e9rhetetlen helyen.<\/li>\n<\/ul>\n<h2>Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k a MedsBase-en<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/asthalin-inhaler\/\"><strong>Asthalin Inhaler \u2014 salbutamol gyorshat\u00e1s\u00fa h\u00f6rg\u0151t\u00e1g\u00edt\u00f3<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/budecort-inhaler\/\"><strong>Budecort Inhaler \u2014 budesonide tartalm\u00fa megel\u0151z\u0151 inhal\u00e1ci\u00f3s szteroid<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/foracort-inhaler\/\"><strong>Foracort Inhaler \u2014 budesonide + formoterol tartalm\u00fa kombin\u00e1lt inhal\u00e1ci\u00f3s szteroid \u00e9s hossz\u00fa hat\u00e1s\u00fa b\u00e9ta-agonist<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/tiova-inhaler\/\"><strong>Tiova Inhaler \u2014 tiotropium tartalm\u00fa hossz\u00fa hat\u00e1s\u00fa muszkarinreceptor-antagonista COPD kezel\u00e9s\u00e9re<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/montair\/\"><strong>Montair \u2014 montelukast tartalm\u00fa leukotri\u00e9nreceptor-antagonista tabletta<\/strong><\/a><\/li>\n<\/ul>\n<h2 id=\"faqs\">Gyakran Ism\u00e9telt K\u00e9rd\u00e9sek<\/h2>\n<h3>Is theophylline still used in modern asthma management?<\/h3>\n<p>Yes, but as third-line add-on. Inhaled \u03b22 agonists, ICS, ICS-LABA, LTRA, and LAMA are first-line; theophylline is added for refractory disease, particularly nocturnal asthma. The narrow therapeutic index and many drug interactions limit its use.<\/p>\n<h3>How is the dose decided?<\/h3>\n<p>Adjusted to serum theophylline level 10\u201320 mg\/L. Check 5 days after starting, after dose change, with new interacting drug, with smoking cessation, and during illness\/fever.<\/p>\n<h3>Why so many interactions?<\/h3>\n<p>Theophylline is metabolised by CYP1A2 \u2014 many drugs raise levels (ciprofloxacin, erythromycin, fluvoxamine, cimetidine) or lower levels (rifampicin, phenytoin, smoking).<\/p>\n<h3>How long does Unicontin-E last?<\/h3>\n<p>The controlled-release tablet provides 12-hour cover. Twice-daily dosing maintains stable serum levels.<\/p>\n<h3>What are the toxic symptoms?<\/h3>\n<p>Severe nausea, persistent vomiting, tachycardia, palpitations, tremor, hyperactivity, seizures (often without warning), arrhythmias, hypotension. Toxicity above 20 mg\/L is an emergency \u2014 withhold dose, check level, supportive care.<\/p>\n<h3>Can I take it with caffeine?<\/h3>\n<p>Caffeine and theophylline are both methylxanthines with overlapping effects. Heavy caffeine can amplify tremor, tachycardia, and insomnia. Reduce caffeine if symptomatic.<\/p>\n<h3>Why does smoking affect dose?<\/h3>\n<p>Smoking induces CYP1A2 (the enzyme that metabolises theophylline). Smokers need higher doses; on stopping, levels rise \u2014 re-titrate.<\/p>\n<h3>Is Unicontin-E safe in pregnancy?<\/h3>\n<p>Generally avoided unless benefit clear. Inhaled therapy is preferred.<\/p>\n<h3>Can I crush or split Unicontin-E tablets?<\/h3>\n<p>No \u2014 controlled-release tablets must be swallowed whole. Crushing destroys the release matrix and risks acute toxicity.<\/p>\n<div style=\"background:#fff3f3;border-left:4px solid #d9534f;padding:14px 18px;margin:24px 0;border-radius:4px;font-size:13px;\"><strong>Orvosi felel\u0151ss\u00e9gi nyilatkozat:<\/strong> Ez az oldal t\u00e1j\u00e9koztat\u00f3 jelleg\u0171, \u00e9s nem helyettes\u00edti a szakorvosi tan\u00e1csot. Mindig konzult\u00e1ljon kvalifik\u00e1lt eg\u00e9szs\u00e9g\u00fcgyi szakemberrel b\u00e1rmilyen inhal\u00e1tor vagy l\u00e9g\u00fati gy\u00f3gyszer elkezd\u00e9se, abbahagy\u00e1sa vagy m\u00f3dos\u00edt\u00e1sa el\u0151tt, k\u00fcl\u00f6n\u00f6sen ha m\u00e1s betegs\u00e9gei vannak, m\u00e1s gy\u00f3gyszereket szed, terhes vagy szoptat, vagy 65 \u00e9v feletti.<\/div>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h3 class=\"wp-block-heading\">Kapcsol\u00f3d\u00f3 alternat\u00edv\u00e1k<\/h3>\n<p>Egy\u00e9b term\u00e9kek a <strong>Kr\u00f3nikus betegs\u00e9gek<\/strong> v\u00e1s\u00e1rl\u00f3k \u00e1ltal szint\u00e9n megtekintett term\u00e9kek:<\/p>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/hu\/topme-xl\/\">Topme XL<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/amifru\/\">Amifru<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/unibrom-eye-drops\/\">Unibrom szemcsepp<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/nise-gel\/\">Nise Gel<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/hu\/dynapar\/\">Dynapar<\/a><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>\u2705 Enyh\u00edti a bronchospazmust<br \/>\n\u2705 Enhances lung function<br \/>\n\u2705 Reduces shortness of breath<br \/>\n\u2705 Improves airway flow<br \/>\n\u2705 Manages asthma symptoms<\/p>\n<p>Unicontin-E contains Theophylline.<\/p>","protected":false},"featured_media":60803,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3681,3141,3223],"product_tag":[3731,4926],"class_list":{"0":"post-60802","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-asthma-copd-treatment","7":"product_cat-category-overview","8":"product_cat-chronic-conditions","9":"product_tag-theophylline","10":"product_tag-unicontin-e","12":"first","13":"instock","14":"shipping-taxable","15":"purchasable","16":"product-type-variable","17":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product\/60802","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/comments?post=60802"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media\/60803"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/media?parent=60802"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_brand?post=60802"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_cat?post=60802"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/hu\/wp-json\/wp\/v2\/product_tag?post=60802"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}